HomeNDC LookupRxCUI directory › RxCUI 1652673

Doxycycline monohydrate 50 MG Oral Tablet — RxCUI 1652673

RxNorm drug concept · Semantic clinical drug
RxCUI 1652673 Semantic clinical drug · SCD ● Current RxNorm concept 26 FDA products 51 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1652673
Official nameDoxycycline monohydrate 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped26
Package NDCs mapped51
Reported Medicaid activity (SDUD)250,306 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The IV form is used when you're not able to swallow or absorb oral medication — for example, if you're too sick, vomiting, or need a faster, more reliable delivery of the antibioti...
  • Why am I getting doxycycline through an IV instead of just taking a pill?
  • It depends on what infection you're being treated for. For most infections, treatment continues for at least 24 to 48 hours after your fever and symptoms have cleared. For somethin...
  • How long will I need to be on this antibiotic?
📖 Read our full Doxycycline Injection guide →

🕸️ Concept Web — How Doxycycline monohydrate 50 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxycycline monohydrate 50 MG Oral Tablet RxCUI 1652673

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Doxycycline 3640
    • Doxycycline monohydrate 203122
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxycycline Oral Tablet 371966
    • Doxycycline monohydrate Oral Tablet 2646460
    • Doxycycline Oral Product 1160778
    • Doxycycline Pill 1160779
    • Doxycycline monohydrate Oral Product 2661810
    • Doxycycline monohydrate Pill 2659349
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Doxycycline monohydrate 50 MG 1649400

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxycycline monohydrate 50 MG SCDC · 1649400
  • Doxycycline Oral Tablet SCDF · 371966
  • Doxycycline monohydrate Oral Tablet SCDFP · 2646460
  • Doxycycline Oral Product SCDG · 1160778
  • Doxycycline Pill SCDG · 1160779
  • Doxycycline monohydrate Oral Product SCDGP · 2661810
  • Doxycycline monohydrate Pill SCDGP · 2659349

📦 FDA Products & Package NDCs

26 products · 51 package NDCs
51 package NDCs map to RxCUI 1652673 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70771-1009-03 30 TABLET, FILM COATED in 1 BOTTLE (70771-1009-3) Doxycycline Zydus Lifesciences Limited 2018-01-11
Observed labelers: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (16) · Sun Pharmaceutical Industries Inc. (10) · Lannett Company, Inc. (6) · Zydus Lifesciences Limited (6) · Zydus Pharmaceuticals USA Inc. (6) · Strides Pharma Science Limited (5) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.